▲ +39.35% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for ANI Pharmaceuticals in the last 3 months. The average price target is $46.00, with a high forecast of $58.00 and a low forecast of $40.00. The average price target represents a 39.35% upside from the last price of $33.01.
The current consensus among 3 polled investment analysts is to buy stock in ANI Pharmaceuticals. This Buy consensus rating has held steady for over two years.
ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract manufacturing for other pharmaceutical companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was founded in 2001 and is headquartered in Baudette, Minnesota.